IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
Weight Loss Correlates with Macrophage Inhibitory Cytokine-1 Expression and Might Influence Outcome in Patients with Advanced Esophageal Squamous Cell Carcinoma
Lu, Zhi-Hao1; Yang, Li2; Yu, Jing-Wei1; Lu, Ming1; Li, Jian1; Zhou, Jun1; Wang, Xi-Cheng1; Gong, Ji-Fang1; Gao, Jing1; Zhang, Xiao-Tian1; Li, Jie1; Li, Yan1; Shen, Lin1
关键词Weight loss esophageal SCC macrophage inhibitory cytokine-1 chemotherapy overall survival
刊名ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
2014
DOI10.7314/APJCP.2014.15.15.6047
15期:15页:6047-6052
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]TGF-BETA SUPERFAMILY ; CANCER CACHEXIA ; CONTROLLED-TRIAL ; MIC-1 ; CHEMOTHERAPY ; PLASMA ; SERUM ; PREVALENCE ; PROGNOSIS ; MORTALITY
英文摘要

Background: Weight loss during chemotherapy has not been exclusively investigated. Macrophage inhibitory cytokine-1 (MIC-1) might play a role in its etiology. Here, we investigated the prognostic value of weight loss before chemotherapy and its relationship with MIC-1 concentration and its occurrence during chemotherapy in patients with advanced esophageal squamous cell carcinoma (ESCC). Materials and Methods: We analyzed 157 inoperable locally advanced or metastatic ESCC patients receiving first-line chemotherapy. Serum MIC-1 concentrations were assessed before chemotherapy. Patients were assigned into two groups according to their weight loss before or during chemotherapy:>5% weight loss group and <= 5% weight loss group. Results: Patients with weight loss>5% before chemotherapy had shorter progression-free survival period (5.8 months vs. 8.7 months; p=0.027) and overall survival (10.8 months vs. 20.0 months; p=0.010). Patients with weight loss >5% during chemotherapy tended to have shorter progression-free survival (6.0 months vs. 8.1 months; p=0.062) and overall survival (8.6 months vs. 18.0 months; p=0.022), and if weight loss was reversed during chemotherapy, survival rates improved. Furthermore, serum MIC-1 concentration was closely related to weight loss before chemotherapy (p=0.001) Conclusions: Weight loss both before and during chemotherapy predicted poor outcome in advanced ESCC patients, and MIC-1 might be involved in the development of weight loss in such patients.

语种英语
WOS记录号WOS:000343723600014
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67873
专题北京大学临床肿瘤学院_胃肠肿瘤中心
北京大学临床肿瘤学院_消化肿瘤内科
作者单位1.Peking Univ Sch Oncol, Beijing Canc Hosp & Inst, Dept GI Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Zhangzhou, Fujian Province, Peoples R China
2.Zhangzhou Municipal Hosp, Dept Oncol, Zhangzhou, Fujian Province, Peoples R China
推荐引用方式
GB/T 7714
Lu, Zhi-Hao,Yang, Li,Yu, Jing-Wei,et al. Weight Loss Correlates with Macrophage Inhibitory Cytokine-1 Expression and Might Influence Outcome in Patients with Advanced Esophageal Squamous Cell Carcinoma[J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION,2014,15(15):6047-6052.
APA Lu, Zhi-Hao.,Yang, Li.,Yu, Jing-Wei.,Lu, Ming.,Li, Jian.,...&Shen, Lin.(2014).Weight Loss Correlates with Macrophage Inhibitory Cytokine-1 Expression and Might Influence Outcome in Patients with Advanced Esophageal Squamous Cell Carcinoma.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION,15(15),6047-6052.
MLA Lu, Zhi-Hao,et al."Weight Loss Correlates with Macrophage Inhibitory Cytokine-1 Expression and Might Influence Outcome in Patients with Advanced Esophageal Squamous Cell Carcinoma".ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 15.15(2014):6047-6052.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Lu, Zhi-Hao]的文章
[Yang, Li]的文章
[Yu, Jing-Wei]的文章
百度学术
百度学术中相似的文章
[Lu, Zhi-Hao]的文章
[Yang, Li]的文章
[Yu, Jing-Wei]的文章
必应学术
必应学术中相似的文章
[Lu, Zhi-Hao]的文章
[Yang, Li]的文章
[Yu, Jing-Wei]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。